
Sign up to save your podcasts
Or


An interview with Dr. Nancy E. Davidson from Fred Hutchinson Cancer Research Center and University of Washington on the guideline update which provides recommendations on systemic therapy for patients with human epidermal growth factor receptor 2 (HER2)–positive advanced breast cancer. Read the full guideline at www.asco.org/breast-cancer-guidelines
By American Society of Clinical Oncology (ASCO)4.6
4444 ratings
An interview with Dr. Nancy E. Davidson from Fred Hutchinson Cancer Research Center and University of Washington on the guideline update which provides recommendations on systemic therapy for patients with human epidermal growth factor receptor 2 (HER2)–positive advanced breast cancer. Read the full guideline at www.asco.org/breast-cancer-guidelines

317 Listeners

498 Listeners

40 Listeners

68 Listeners

17 Listeners

58 Listeners

187 Listeners

32 Listeners

22 Listeners

366 Listeners

227 Listeners

58 Listeners

192 Listeners

44 Listeners

3 Listeners